Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2
Introduction. Ventilator Associated Pneumonia (VAP) is associated with significant cost, morbidity, and mortality. There is limited data on the incidence of VAP, appropriate antibiotic timing, and the impact of multidrug resistant VAP in intubated Coronavirus disease-19 (COVID-19) patients. Methods....
Saved in:
Main Authors: | Seife Yohannes, Zaki Ahmed, Rachel Schelling, Swaminathan Perinkulam Sathyanarayanan, Alexandra Pratt, Mathew P. Schreiber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2022/9730895 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Continuous Infusion of Ketamine in Mechanically Ventilated Patients with SARS-CoV-2
by: Brian Phan, et al.
Published: (2024-01-01) -
Prevalence of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates in Nepal
by: Ranjeeta Odari, et al.
Published: (2022-01-01) -
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
by: Mohammad Alghounaim, et al.
Published: (2022-06-01) -
Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01) -
Detection of Delafloxacin Resistance Mechanisms in Multidrug-Resistant <i>Klebsiella pneumoniae</i>
by: András Kubicskó, et al.
Published: (2025-01-01)